predicTox: an integrated database of clinical risk frequencies and human gene expression signatures for cardiotoxic drugs
Database · 2026
DOI: 10.1093/database/baag003 ↗At a glance
Journal article in Database, 2026. Written by Jens Hansen and 10 co-authors. Institution: Department of Pharmacological Sciences and Systems Biomedicine Institute Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, …. Major MEDLINE topics: Transcriptome, Cardiotoxins, Cardiotoxicity, Databases, Genetic. 32 references. The full text is freely available (open access, CC BY 4.0). Funded by: NHGRI NIH HHS, NIH HHS, U.S. Food and Drug Administration.
Abstract (original language)
We recently used drug-induced transcriptomic responses and whole-genome sequences in healthy human induced pluripotent stem cell (iPSC)-derived cardiomyocytes to identify cellular pathways and genomic variants potentially associated with the cardiotoxic effects of tyrosine kinase inhibitors (TKIs) and anthracyclines. Here, we describe predicTox (www.predictox.org), an interactive website that organizes our data and its integration with knowledge from cell pathways and genomic databases. DrugTox summary cards give results of these analyses and metadata for each drug. Fields include cardiotoxicity risk scores curated from the FDA Adverse Event Reporting System, cell pathways, and genomic variants potentially associated with drug-induced cardiotoxicity. At a detailed level, predicTox provides a ranked list of up- and downregulated pathways that are predominantly induced by cardiotoxic TKIs as well as lists of their pathway genes and the specific cardiotoxic TKIs inducing those pathways. predicTox provides downloadable lists of drug-induced differentially expressed genes and pathways as well as drug-related genomic variants associated with cardiotoxicity. Statistical metrics are given. Mathematical models allow simulation of drug effects on heart physiology. Building on the results of our algorithm for independent reidentification of the well-known rs2229774 variant for anthracycline-induced cardiotoxicity, we describe how our data can be queried to identify potential variants associated with drug-induced cardiotoxicity by affecting a drug’s pharmacodynamics and pharmacokinetics.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Pharmacological Sciences and Systems Biomedicine Institute Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, USA.
- Office of Clinical Pharmacology, Office of Translational Science, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.
- Predictive Safety Testing Consortium,Critical Path Institute, 1840 E River Rd, Tucson, AZ 85718, USA.
ORCID profiles: Jens Hansen, Ravi Iyengar
Funding
- NHGRI NIH HHS
- NIH HHS
- U.S. Food and Drug Administration
- National Institutes of Health
Cite
APA
Hansen, J., Martinez, P., Yadaw, A. S., Xiong, Y., Racz, R., Pacanowski, M. R., Hopkins, L. L., King, N. M. P., Abernethy, D., Sobie, E., & Iyengar, R. (2026). predicTox: an integrated database of clinical risk frequencies and human gene expression signatures for cardiotoxic drugs. Database. https://doi.org/10.1093/database/baag003
Vancouver
Hansen J, Martinez P, Yadaw AS, Xiong Y, Racz R, Pacanowski MR, et al. predicTox: an integrated database of clinical risk frequencies and human gene expression signatures for cardiotoxic drugs. Database. 2026. doi:10.1093/database/baag003
BibTeX
@article{Hansen2026,
author = {Hansen, Jens and Martinez, Pedro and Yadaw, Arjun S and Xiong, Yuguang and Racz, Rebecca and Pacanowski, Michael R and Hopkins, Laura L and King, Nicholas M P and Abernethy, Darrell and Sobie, Eric and Iyengar, Ravi},
title = {predicTox: an integrated database of clinical risk frequencies and human gene expression signatures for cardiotoxic drugs},
journal = {Database},
year = {2026},
doi = {10.1093/database/baag003}
}
EUVIMED